Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detail2014 ESC/EACTS guidelines on myocardial revascularization.
Windecker, Stephan; Kolh, Philippe ULg; Alfonso, Fernando et al

in Revista espanola de cardiologia (English ed.) (2015), 68(2), 144

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detail2014 ESC/ESA Guidelines on Non-cardiac Surgery: Cardiovascular Assessment and Management.
Kristensen, Steen Dalby; Knuuti, Juhani; Saraste, Antti et al

in European Heart Journal (2014), 35(35), 2383-431

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detail2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.
Roffi, Marco; Patrono, Carlo; Collet, Jean-Philippe et al

in Revista espanola de cardiologia (English ed.) (2015), 68(12), 1125

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detail2015 ESC Guidelines for the management of infective endocarditis.
Habib, Gilbert; LANCELLOTTI, Patrizio ULg; Antunes, Manuel J. et al

in Revista espanola de cardiologia (English ed.) (2016), 69(1), 69

Detailed reference viewed: 17 (2 ULg)
Full Text
Peer Reviewed
See detail2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension : web addenda
GALIE, Nazzareno; HUMBERT, Marc; VACHIERY, Jean-Luc et al

in European Respiratory Journal (2015)

Detailed reference viewed: 26 (0 ULg)
Full Text
Peer Reviewed
See detail2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galie, Nazzareno; Humbert, Marc; Vachiery, Jean-Luc et al

in The European respiratory journal (2015), 46(4), 903-75

Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management ... [more ▼]

Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk-benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. [less ▲]

Detailed reference viewed: 27 (1 ULg)
Full Text
See detail2015 FMA Annual Meeting
Platania, Federico ULg; Lambert, Marie ULg; Moreno, Manuel

Scientific conference (2015, October)

In this paper we develop a novel valuation model and methodology to value a pharmaceutical R&D project based on real options approach. The real options approach enables the possibility of optimally ... [more ▼]

In this paper we develop a novel valuation model and methodology to value a pharmaceutical R&D project based on real options approach. The real options approach enables the possibility of optimally abandon the project before completion whenever the investment cost turns out to be larger than the expected net cash flow stream. On the other hand, the proposed model accounts for two different sources of uncertainty, those are technical and economic risk. This model incor- porates a novel economic state vector where each economic state captures the interaction among different market and economic forces using Fourier series as the particular basis for the economic function space. In this sense, Fourier series are considered as an aggregate of forces playing a relevant role in the process evolution determining the cash flow structure and also allowing us to properly define an economic scenario where the project will be developed. [less ▲]

Detailed reference viewed: 14 (0 ULg)